Contact
searchSearch
HMP Global

Coronary In-Stent Restenosis: An Algorithmic Approach to Diagnosis and Treatment

News

ACC 2026
Boston Scientific Presents Two Late-Breaking Trials at ACC 2026 Highlighting New Evidence in Stroke Prevention for AFib and Treatment of Intermediate-Risk Pulmonary Embolism
03/30/2026
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of...
03/30/2026
Cath Lab Digest
Interventional Cardiology
Philips Launches IntraSight Plus to Simplify Coronary Interventions and Advance Precision Care
03/25/2026
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional...
03/25/2026
Vascular Disease Management
Endovascular Devices
Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML)
03/19/2026
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026...
03/19/2026
Vascular Disease Management
Rob Williamson, RAMPART CRO
Industry Leaders
RAMPART Appoints Rob Williamson as Chief Revenue Officer
02/12/2026
As Chief Revenue Officer, Rob Williamson will lead Rampart’s U.S. Sales organization, focusing on revenue growth, field execution, and team expansion.
As Chief Revenue Officer, Rob Williamson will lead Rampart’s U.S. Sales organization, focusing on revenue growth, field execution, and team expansion.
As Chief Revenue Officer, Rob...
02/12/2026
Cath Lab Digest
AI + ECG
Study Shows AccurKardia’s AI-Enabled ECG Can Detect Aortic Stenosis Years Before Valve Replacement and Improve Mortality Risk Prediction
02/11/2026
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
The study found that AK-AVS can...
02/11/2026
Cath Lab Digest
The Salus and Tallahassee Memorial HealthCare teams celebrate after the first AeroShield case.
Radiation Protection Systems
Tallahassee Memorial HealthCare Advances Cath Lab Safety Through First-in-the-World Technology Adoption
02/10/2026
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Salus Scientific and Tallahassee...
02/10/2026
Cath Lab Digest
Thrombectomy
Avantec Vascular, a NIPRO Company, Announces FDA 510(k) Clearance of Thrombectomy System
02/10/2026
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California...
02/10/2026
Cath Lab Digest
Heart Disease and Flu
Mount Sinai Scientists Uncover Link Between Influenza and Heart Disease
02/09/2026
New York, NY – Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk...
New York, NY – Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk...
New York, NY – Mount Sinai...
02/09/2026
Cath Lab Digest
Transseptal Access
AF Symposium 2026: New Data Show Atraverse Medical’s HOTWIRE™ System Mitigates Unintended Left Atrial Injury With Reduced RF Delivery
02/09/2026
The HOTWIRE™ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient outcomes with the best-in-class platform for...
The HOTWIRE™ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient outcomes with the best-in-class platform for...
The HOTWIRE™ Transseptal Access...
02/09/2026
EP Lab Digest
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest

beta blockers
Stopping Beta-Blockers After Heart Attack Safe for Low-Risk Patients
04/02/2026
“In appropriately selected patients who survived a heart attack and do not have heart failure or left ventricular systolic dysfunction, routine continuation of beta-blockers indefinitely may not be necessary,” said Joo-Yong Hahn, MD.
“In appropriately selected patients who survived a heart attack and do not have heart failure or left ventricular systolic dysfunction, routine continuation of beta-blockers indefinitely may not be necessary,” said Joo-Yong Hahn, MD.
“In appropriately selected...
04/02/2026
Cath Lab Digest
AI Predictive Value
Including AI-Derived Heart Fat Measurement Improves Accuracy of Cardiovascular Disease Risk Prediction
04/02/2026
The study followed nearly 12,000 adults for approximately 16 years. Investigators applied AI to participants' standard coronary artery calcium scans to measure fat surrounding the heart.
The study followed nearly 12,000 adults for approximately 16 years. Investigators applied AI to participants' standard coronary artery calcium scans to measure fat surrounding the heart.
The study followed nearly 12,000...
04/02/2026
Cath Lab Digest
JIC logo
CRT 2026
Accelerating Adoption of Digital Health Technologies by Use of Real-World Evidence and Predetermined Change Control Plans
03/31/2026
Laura Simson, MA
At his CRT 2026 session, Matthew Beckwith of the FDA outlined updated guidance on real-world evidence and introduced Predetermined Change Control Plans for artificial intelligence AI-enabled medical devices.
At his CRT 2026 session, Matthew Beckwith of the FDA outlined updated guidance on real-world evidence and introduced Predetermined Change Control Plans for artificial intelligence AI-enabled medical devices.
At his CRT 2026 session, Matthew...
03/31/2026
Journal of Invasive Cardiology
JIC logo
CRT 2026
Keynote Lecture: Concomitant Surgical Ablation of Atrial Fibrillation – Current Status and Recommendations
03/31/2026
Laura Simson, MA
At his CRT 2026 Keynote Lecture, Dr James L. Cox emphasized the importance of treating atrial fibrillation during cardiac surgery, underscoring that failure to do so significantly worsens long-term outcomes.
At his CRT 2026 Keynote Lecture, Dr James L. Cox emphasized the importance of treating atrial fibrillation during cardiac surgery, underscoring that failure to do so significantly worsens long-term outcomes.
At his CRT 2026 Keynote Lecture,...
03/31/2026
Journal of Invasive Cardiology
PCSK9 Inhibitors
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
03/31/2026
Treatment with enlicitide resulted in statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) compared to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe at eight weeks (day 56)...
Treatment with enlicitide resulted in statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) compared to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe at eight weeks (day 56)...
Treatment with enlicitide...
03/31/2026
Cath Lab Digest
Apurva Patel headshot
ACC 2026
Tailored Solutions for Structural Valve Degeneration: Valve-in-Valve-in-Valve TAVR With Coronary Leaflet Modification and Balloon Valve Fracture
03/31/2026
Apurva Patel, MD, FACC, FSCAI
Dr Apurva Patel discusses insights from the study, “Tailored Solutions for Structural Valve Degeneration: Valve-in-Valve-in-Valve TAVR With Coronary Leaflet Modification and Balloon Valve Fracture,” presented at the 2026 ACC Scientific...
Dr Apurva Patel discusses insights from the study, “Tailored Solutions for Structural Valve Degeneration: Valve-in-Valve-in-Valve TAVR With Coronary Leaflet Modification and Balloon Valve Fracture,” presented at the 2026 ACC Scientific...
Dr Apurva Patel discusses...
03/31/2026
Journal of Invasive Cardiology
Saad Ur Rahman headshot
ACC 2026
National Trends in Aortic Stenosis Mortality in the Pre- and Post-TAVR Eras in the United States, 1999 to 2023
03/31/2026
Saad Ur Rahman, MD
Dr Saad Ur Rahman discusses findings from “National Trends in Aortic Stenosis Mortality in the Pre- and Post-TAVR Eras in the United States 1999–2023,” presented at the 2026 ACC Scientific Sessions.
Dr Saad Ur Rahman discusses findings from “National Trends in Aortic Stenosis Mortality in the Pre- and Post-TAVR Eras in the United States 1999–2023,” presented at the 2026 ACC Scientific Sessions.
Dr Saad Ur Rahman discusses...
03/31/2026
Journal of Invasive Cardiology
JIC logo
CRT 2026
New Generation Devices for Left Atrial Appendage Closure
03/30/2026
Laura Simson, MA
Dr Devi Nair's session at CRT 2026 reviewed the rapidly evolving landscape of next-generation left atrial appendage closure devices for stroke prevention in atrial fibrillation, emphasizing iterative improvements in plug and plication...
Dr Devi Nair's session at CRT 2026 reviewed the rapidly evolving landscape of next-generation left atrial appendage closure devices for stroke prevention in atrial fibrillation, emphasizing iterative improvements in plug and plication...
Dr Devi Nair's session at CRT...
03/30/2026
Journal of Invasive Cardiology
ACC 2026
Medtronic ALERT Study Reveals AI-Enabled Clinician Alerts Significantly Improve Evaluation and Valve Intervention for Patients With Heart Valve Disease 
03/30/2026
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The study utilized Tempus Next,...
03/30/2026
Cath Lab Digest
Roxana Mehran, MD
ACC 2026
Mount Sinai’s Roxana Mehran, MD, named President of the American College of Cardiology
03/30/2026
The American College of Cardiology (ACC) has named Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI, as its new President.
The American College of Cardiology (ACC) has named Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI, as its new President.
The American College of...
03/30/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use